-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
ChemChina extends Syngenta tender offer deadline
Ramsey to Retire from Syngenta CFO PostUSAgNet – 09/08/2016After a career at Syngenta and legacy companies spanning 32 years, John Ramsay has chose to retire from the company at the end of September in order to pursue other interests.
Advertisement
A spokesman for Syngenta said it had nothing to add beyond Wednesday’s statement.
British-born Ramsay, 58, was there at the creation of Syngenta in 1999, when Novartis AG and AstraZeneca Plc announced a merger of their crop-care businesses.
Ramsay served as interim CEO until June, and SYT says he was central to its pending merger with ChemChina.
A United States national security regulator approved the merger in August, and the companies said a number of antitrust regulators around the world still needed to approve the deal. He “mastered” communication to investors on why cash flow sometimes went through erratic changes because of the unpredictable influence of weather on the business, he said.
Patrick is set to have a different CFO experience than Ramsay’s, according to Faitz. Further management changes are expected at Syngenta, which could see additional employees joining from DuPont, said the people.
The proposed merger is not the only one in the sector, with German chemicals and pharmaceuticals giant Bayer on Monday sweetening its offer for Monsanto to US$127.50 per share, which would bring bring the deal’s total value to nearly US$66 billion including debt.
Advertisement
ChemChina said that as of Sep 2 almost 17.9 million ordinary shares had been tendered under the offer.